PB2178: OUTCOMES OF REDUCED DOSE TEAM (THIOTEPA, ETOPOSIDE, CYTARABINE, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HODGKIN AND NON-HODGKIN LYMPHOMA: A MONOCENTRIC EXPERIENCE

Detalles Bibliográficos
Autores principales: Di Folca, S., Marafioti, V., barbato, S., Avilia, S., Grimaldi, F., Severino, A., Picardi, M., Luciano, L., Battipaglia, G., Pane, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431468/
http://dx.doi.org/10.1097/01.HS9.0000851540.26904.c2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431468/
http://dx.doi.org/10.1097/01.HS9.0000851540.26904.c2

Ejemplares similares